A detailed history of Evergreen Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Evergreen Capital Management LLC holds 53,950 shares of ABBV stock, worth $10.5 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
53,950
Previous 53,962 0.02%
Holding current value
$10.5 Million
Previous $9.83 Million 5.83%
% of portfolio
0.36%
Previous 0.4%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $1,857 - $2,169
-12 Reduced 0.02%
53,950 $9.25 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $1.84 Million - $2.09 Million
-11,484 Reduced 17.55%
53,962 $9.83 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $334,643 - $376,887
2,432 Added 3.86%
65,446 $10.1 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $645,106 - $746,804
4,829 Added 8.3%
63,014 $9.39 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $456,496 - $568,080
-3,445 Reduced 5.59%
58,185 $7.84 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $241,787 - $278,454
1,672 Added 2.79%
61,630 $9.82 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $134,990 - $161,889
976 Added 1.65%
59,958 $9.7 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $561,668 - $644,197
4,185 Added 7.64%
58,982 $7.92 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $492,266 - $625,831
-3,577 Reduced 6.13%
54,797 $8.39 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $445,696 - $552,983
-3,377 Reduced 5.47%
58,374 $9.46 Million
Q4 2021

Mar 11, 2022

BUY
$107.43 - $135.93 $846,226 - $1.07 Million
7,877 Added 14.62%
61,751 $8.36 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $684,790 - $777,340
6,436 Added 13.57%
53,874 $5.81 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $321,311 - $357,959
3,054 Added 6.88%
47,438 $5.34 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $704,335 - $775,388
6,885 Added 18.36%
44,384 $4.8 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $450,744 - $608,552
5,600 Added 17.56%
37,499 $4.02 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $197,764 - $232,110
2,302 Added 7.78%
31,899 $2.79 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $329,137 - $440,435
4,486 Added 17.86%
29,597 $2.91 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $877,716 - $1.33 Million
13,608 Added 118.3%
25,111 $1.91 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $314,198 - $393,129
4,356 Added 60.95%
11,503 $1.02 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $98,311 - $118,198
-1,561 Reduced 17.93%
7,147 $541,000
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $985 - $1,259
-15 Reduced 0.17%
8,708 $633,000
Q1 2019

May 10, 2019

SELL
$77.14 - $90.79 $13,962 - $16,432
-181 Reduced 2.03%
8,723 $703,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $57,531 - $70,951
739 Added 9.05%
8,904 $821,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $5,779 - $6,424
-65 Reduced 0.79%
8,165 $772,000
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $2,872 - $3,399
-32 Reduced 0.39%
8,230 $763,000
Q1 2018

May 10, 2018

BUY
$92.01 - $123.21 $200,397 - $268,351
2,178 Added 35.8%
8,262 $782,000
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $544,883 - $597,509
6,084
6,084 $588,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.